Victory Capital Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Victory Capital Management’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-7,724	Closed	-$339K	–	2868
2021 Q2	$339K	Sell	7,724 -378	-5%	-$21.1K	﹤0.01%	2375
2021 Q1	$588K	Sell	8,102 -411	-5%	-$29.2K	﹤0.01%	2119
2020 Q4	$368K	Sell	8,513 -599	-7%	-$26.8K	﹤0.01%	2216
2020 Q3	$374K	Sell	9,112 -3,812	-29%	-$197K	﹤0.01%	2076
2020 Q2	$775K	Sell	12,924 -12,923	-50%	-$1.18M	﹤0.01%	1836
2020 Q1	$1.95M	Buy	25,847 +12,211	+90%	+$1.41M	﹤0.01%	1611
2019 Q4	$1.88M	Hold	13,636	–	–	﹤0.01%	1534
2019 Q3	$1.62M	Buy	13,636 +12,964	+1,929%	+$1.81M	﹤0.01%	1537
2019 Q2	$94K	Hold	672	–	–	﹤0.01%	1639
2019 Q1	$120K	Hold	672	–	–	﹤0.01%	1644
2018 Q4	$106K	Buy	+672	New	+$100K	﹤0.01%	1637

Other funds holding ORTX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Victory Capital Management's ORTX Position: Q3 2021 in Review

Victory Capital Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q3 2021, closing a stake of 7,724 shares — an estimated $339K sold.

Victory Capital Management first reported a position in ORTX in Q4 2018 and held it in 11 quarters. The position peaked at $1.95M in Q1 2020. 79 funds tracked by Wall St. Rank hold ORTX as of Q3 2021.

Victory Capital Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q3 2021 after selling out during the quarter.
Victory Capital Management sold 7,724 Orchard Therapeutics plc American Depositary Shares shares in Q3 2021, an estimated $339K.
Victory Capital Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2018 and held it in 11 quarters.
Victory Capital Management's Orchard Therapeutics plc American Depositary Shares position peaked at $1.95M in Q1 2020.
79 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q3 2021.

Based on Victory Capital Management's 13F filing for Q3 2021, filed 2 Nov 2021.